Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 33.79%94.21B | 5.03%381.66B | -10.01%70.42B | 7.24%363.37B | -0.52%99.63B | 13.07%99.36B | 9.73%86.12B | 8.20%78.25B | 11.92%338.83B | -2.37%100.15B |
| Cost of revenue | 23.19%74.3B | 2.17%310.02B | -11.98%60.31B | 3.74%303.42B | -2.29%82.45B | 7.94%79.69B | 6.05%72.77B | 4.37%68.52B | 11.91%292.47B | -3.75%84.38B |
| Gross profit | 97.00%19.9B | 19.52%71.65B | 3.88%10.1B | 29.30%59.95B | 8.98%17.19B | 39.98%19.67B | 35.29%13.36B | 45.99%9.73B | 12.00%46.36B | 5.73%15.77B |
| Operating expense | 19.86%9.93B | 9.66%39.63B | 9.67%8.28B | 14.91%36.14B | 27.98%11.58B | 31.94%9.46B | -2.49%7.56B | 0.84%7.55B | 14.98%31.45B | 11.27%9.05B |
| Staff costs | 18.82%3.61B | 8.66%15.62B | 1.37%3.04B | 19.34%14.38B | 27.77%4.7B | 33.90%3.71B | 3.12%2.98B | 10.34%3B | 11.05%12.05B | 16.55%3.68B |
| Selling and administrative expenses | ---- | 2.34%3.72B | ---- | -2.34%3.63B | ---- | ---- | ---- | ---- | 0.22%3.72B | ---- |
| -General and administrative expense | ---- | 2.34%3.72B | ---- | -2.34%3.63B | ---- | ---- | ---- | ---- | 0.22%3.72B | ---- |
| Depreciation and amortization | ---- | 25.36%2.62B | ---- | 14.49%2.09B | ---- | ---- | ---- | ---- | 37.20%1.82B | ---- |
| -Depreciation | ---- | 25.36%2.62B | ---- | 14.49%2.09B | ---- | ---- | ---- | ---- | 37.20%1.82B | ---- |
| Rent and land expenses | 80.00%144M | 2.64%3.15B | -46.31%80M | -1.06%3.07B | -0.51%2.75B | 11.69%86M | -22.52%86M | -1.97%149M | 3.23%3.1B | 0.25%2.76B |
| Other operating expenses | 19.54%6.17B | 11.95%14.53B | 17.21%5.16B | 20.58%12.98B | 45.96%-1.58B | 31.05%5.66B | -5.42%4.5B | -4.65%4.41B | 27.15%10.77B | -4.08%-2.93B |
| Operating profit | 448.08%9.98B | 34.48%32.01B | -16.24%1.82B | 59.65%23.8B | -16.57%5.61B | 48.34%10.22B | 173.33%5.8B | 362.44%2.17B | 6.20%14.91B | -0.90%6.73B |
| Net non-operating interest income (expenses) | -9.52%57M | 124.00%280M | 200.00%63M | 992.86%125M | 414.29%22M | 488.89%53M | 462.50%29M | 362.50%21M | 80.28%-14M | 56.25%-7M |
| Non-operating interest income | 19.49%141M | 32.93%549M | 35.63%118M | 56.44%413M | 51.35%112M | 50.65%116M | 71.93%98M | 55.36%87M | 59.04%264M | 37.04%74M |
| Non-operating interest expense | 52.73%84M | -6.60%269M | -16.67%55M | 3.60%288M | 11.11%90M | -7.35%63M | 6.15%69M | 3.13%66M | 17.30%278M | 15.71%81M |
| Net investment income | 3.63%713M | -1.15%947M | -6.27%688M | 14.18%958M | 2.84%-137M | 49.25%200M | -41.03%161M | 28.10%734M | 4.48%839M | -233.02%-141M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 109.42%2.71B | 311.11%37M | 522.60%1.3B | 492.08%1.2B | 86M | -33.33%4M | 9M | -81.69%208M | -82.22%202M |
| Income from associates and other participating interests | -124.53%-13M | 118.58%400M | 151.96%53M | 112.79%183M | -11.92%133M | 13,200.00%133M | -44.12%19M | -2.00%-102M | -59.81%86M | 33.63%151M |
| Special income (charges) | 1.03B | 29.08%-278M | 0 | -188.24%-392M | -48.84%-64M | -750.00%-102M | -61.19%-216M | -118.87%-10M | 72.64%-136M | 33.85%-43M |
| Less:Other special charges | ---1.19B | 145.19%255M | ---- | 153.66%104M | 72.97%64M | 275.00%30M | --0 | 118.52%10M | -14.58%41M | 362.50%37M |
| Less:Write off | --160M | -92.01%23M | ---- | 203.16%288M | --0 | 1,700.00%72M | 157.14%216M | --0 | -78.84%95M | -89.47%6M |
| Other non-operating income (expenses) | 17.77%338M | 33.09%1.44B | -1.03%287M | 12.47%1.08B | 157.95%454M | -49.88%205M | -21.30%133M | 39.42%290M | -13.02%962M | -37.59%176M |
| Income before tax | 310.66%12.1B | 38.65%37.51B | -5.39%2.95B | 60.53%27.05B | 2.19%7.22B | 45.20%10.79B | 140.98%5.93B | 3,094.23%3.11B | 0.75%16.85B | -15.34%7.06B |
| Income tax | 332.01%3.15B | 36.62%9.48B | -26.46%728M | 67.97%6.94B | -1.76%1.51B | 40.04%2.64B | 314.02%1.8B | 258.70%990M | -19.67%4.13B | -35.27%1.53B |
| Net income | 303.65%8.95B | 39.35%28.02B | 4.47%2.22B | 58.12%20.11B | 3.29%5.71B | 46.98%8.15B | 103.70%4.13B | 657.22%2.12B | 9.83%12.72B | -7.43%5.53B |
| Net income continuous operations | 303.65%8.95B | 39.35%28.02B | 4.43%2.22B | 58.12%20.11B | 3.29%5.71B | 46.96%8.15B | 103.80%4.13B | 658.95%2.12B | 9.83%12.72B | -7.43%5.53B |
| Noncontrolling interests | -101.58%-3M | -21.29%392M | 25.83%190M | 1.43%498M | -26.58%163M | 21.84%106M | -4.88%78M | 51.00%151M | 991.11%491M | 7.77%222M |
| Net income attributable to the company | 341.84%8.96B | 40.89%27.63B | 2.79%2.03B | 60.40%19.61B | 4.54%5.55B | 47.36%8.04B | 108.39%4.05B | 509.98%1.97B | 6.00%12.23B | -7.96%5.31B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 341.84%8.96B | 40.89%27.63B | 2.79%2.03B | 60.40%19.61B | 4.54%5.55B | 47.36%8.04B | 108.39%4.05B | 509.98%1.97B | 6.00%12.23B | -7.96%5.31B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 345.04%67.98 | 40.74%208.075 | 2.62%15.275 | 60.10%147.84 | 4.32%41.805 | 47.08%60.625 | 107.72%30.525 | 508.37%14.885 | 9.04%92.345 | -6.07%40.075 |
| Diluted earnings per share | 345.04%67.98 | 40.74%208.075 | 2.62%15.275 | 60.10%147.84 | 4.33%41.7965 | 47.00%60.5939 | 107.27%30.4445 | 508.37%14.885 | 9.04%92.345 | -6.10%40.0625 |
| Dividend per share | 0 | 40.34%83.5 | 0 | 88.89%59.5 | 145.45%40.5 | 0 | 26.67%19 | 0 | 5.00%31.5 | 6.45%16.5 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |